Skip to content
AUA News

AUA News

Primary Menu
  • Home
  • Sample Page
  • Home
  • News
  • OpenAI CEO Sam Altman among investors in embryo gene-editing venture
  • News

OpenAI CEO Sam Altman among investors in embryo gene-editing venture

admin November 19, 2025
OpenAI CEO Sam Altman among investors in embryo gene-editing venture

OpenAI CEO Sam Altman among investors in embryo gene-editing venture


San Francisco-based startup Preventive has raised nearly $30 million from investors, including OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong, to develop embryo gene-editing technology aimed at preventing hereditary diseases.

Continue Reading

Previous: Nicki Minaj says religious freedom advocacy is about ‘uniting humanity’ at UN event
Next: Mom pressured to take abortion drugs says a pregnancy center saved her baby’s life

Related Stories

Jan Markell: Ten Prominent Markers Of Jesus’ Soon Return Jan Markell: Ten Prominent Markers Of Jesus’ Soon Return
  • News

Jan Markell: Ten Prominent Markers Of Jesus’ Soon Return

March 10, 2026
University of North Texas to debut bachelor of science in AI degree University of North Texas to debut bachelor of science in AI degree
  • News

University of North Texas to debut bachelor of science in AI degree

March 9, 2026
Cities Church pastor responds to Don Lemon’s accusations of white supremacy Cities Church pastor responds to Don Lemon's accusations of white supremacy
  • News

Cities Church pastor responds to Don Lemon’s accusations of white supremacy

March 9, 2026
Copyright © 2024. All rights reserved.